Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
BLX 0.5ELF.TO 0.09RY.TO 3.05PEY.TO 0.26CP.TO -0.12BRK.B -0.57MSFT -5.93META 6.73
Valeant Pharmaceuticals (VRX.TO)

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Jul 04, 2003
Likes their product lines. May be getting a little bit high.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$62.20

Stock price when the opinion was issued

Healthcare
Track your Stocks in your Watch List
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 13, 2003
Some renewed short selling has has brought the price down. Volatile, but trend continues to be upward.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$65.33

Stock price when the opinion was issued

Healthcare
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Jun 10, 2003
Extremely volatile. Company has executed in terms of delivering earnings, new drugs. Treat as a trade.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$65.56

Stock price when the opinion was issued

Healthcare
HOLD

Valeant Pharmaceuticals(VRX.TO)

Jun 03, 2003
Has had a huge run. Making some revenue through their acquisitions. Has some upside left. A little ahead of itself.
Photo of Richard StoneRichard StoneUnlock Rating
$66.34

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

May 30, 2003
Up against strong technical resistance that it has to break through.
Photo of Ross HealyRoss HealyUnlock Rating
$64.09

Stock price when the opinion was issued

Healthcare
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

May 29, 2003
Has had a good run because of speculation they will get approval on Welbutron (?). A little rich right now. Wait for a pull back.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$62.99

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

May 13, 2003
Prescription growth on new drugs is good. Continues to be strong.
Photo of David BurrowsDavid BurrowsUnlock Rating
$58.36

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

May 06, 2003
Fundamentally likes the stock. Earnings are there. Buy and hold.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$55.40

Stock price when the opinion was issued

Healthcare
Track your Stocks in your Watch List
BUY

Valeant Pharmaceuticals(VRX.TO)

May 02, 2003
Volatile, but very interesting. Should go higher.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$53.90

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 30, 2003
Likes the fundamentals and looks cheap.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$52.33

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 29, 2003
Volatile. A new drug is coming out. Has some decent longer term fundamentals.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$55.19

Stock price when the opinion was issued

Healthcare
WAIT

Valeant Pharmaceuticals(VRX.TO)

Apr 28, 2003
The fair market value is $90.On a technical basis it is trying to break through its former price tobook value peak. Could have a good move.
Photo of Ross HealyRoss HealyUnlock Rating
$60.90

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 28, 2003
Likes the company, but getting a little high. Expectations may be too high on their new drug.
Photo of John ZechnerJohn ZechnerUnlock Rating
$60.90

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 25, 2003
Outlook for them is quite strong. Interesting products coming along.
Photo of Robert FloydRobert FloydUnlock Rating
$62.50

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Apr 24, 2003
In a solid uptrend.
Photo of Lou SchizasLou SchizasUnlock Rating
$63.37

Stock price when the opinion was issued

Healthcare
Showing 541 to 555 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

AVGO -17.23$376.71
CCO.TO 1.26$151.04
TOU.TO -0.47$60.79
BTE.TO -0.22$5.91
ADM -1.25$78.02

Today's Top Picks

BLX 0.5$59.17
ELF.TO 0.09$16.98
RY.TO 3.05$281.51
PEY.TO 0.26$24.91
CP.TO -0.12$124.8

Popular Articles

Latest Sell Signals

OTEX.TO 0.14$30.96
BSX 0.16$46.92
GIL.TO -16.24$70.39
SHOP.TO 1.22$158.49
WCN.TO 3.21$219.59

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica